IntelGenx, RedHill deal

IntelGenx signed a binding term-sheet with RedHill covering a proposed license for IntelGenx's anti-migraine film product, which has completed a Phase I trial. Under the terms of the proposed deal, RedHill would receive exclusive, worldwide rights to market the serotonin (5-HT) antagonist, which is delivered by IntelGenx's VersaFilm oral disintegrating film. ...